XML 89 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($)
$ in Millions
3 Months Ended 4 Months Ended 9 Months Ended 12 Months Ended
Feb. 23, 2019
Dec. 01, 2018
Sep. 08, 2018
Feb. 24, 2018
Dec. 02, 2017
Sep. 09, 2017
Jun. 16, 2018
Jun. 17, 2017
Nov. 30, 2019
Dec. 01, 2018
Feb. 23, 2019
Feb. 24, 2018
Feb. 25, 2017
Concentration Risk [Line Items]                          
Net sales and other revenue $ 14,016.6 $ 13,840.4 $ 14,024.1 $ 14,033.7 $ 13,599.2 $ 13,831.7 $ 18,653.4 $ 18,460.0 $ 47,018.3 $ 46,517.9 $ 60,534.5 $ 59,924.6 $ 59,678.2
Sales Revenue, Product Line | Product Concentration Risk                          
Concentration Risk [Line Items]                          
Net sales and other revenue                 $ 47,018.3 $ 46,517.9      
Percentage of total net sales and other revenue                 100.00% 100.00% 100.00% 100.00% 100.00%
Non-Perishables                          
Concentration Risk [Line Items]                          
Net sales and other revenue                     $ 26,371.8 $ 26,522.0 $ 26,699.2
Non-Perishables | Sales Revenue, Product Line | Product Concentration Risk                          
Concentration Risk [Line Items]                          
Net sales and other revenue                 $ 20,362.4 $ 20,186.0      
Percentage of total net sales and other revenue                 43.30% 43.40% 43.60% 44.30% 44.70%
Perishables                          
Concentration Risk [Line Items]                          
Net sales and other revenue                     $ 24,920.9 $ 24,583.7 $ 24,398.5
Perishables | Sales Revenue, Product Line | Product Concentration Risk                          
Concentration Risk [Line Items]                          
Net sales and other revenue                 $ 19,347.7 $ 19,099.1      
Percentage of total net sales and other revenue                 41.10% 41.00% 41.20% 41.00% 40.90%
Pharmacy                          
Concentration Risk [Line Items]                          
Net sales and other revenue                     $ 4,986.6 $ 5,002.6 $ 5,119.2
Pharmacy | Sales Revenue, Product Line | Product Concentration Risk                          
Concentration Risk [Line Items]                          
Net sales and other revenue                 $ 3,958.2 $ 3,847.0      
Percentage of total net sales and other revenue                 8.40% 8.30% 8.20% 8.30% 8.60%
Fuel                          
Concentration Risk [Line Items]                          
Net sales and other revenue                     $ 3,455.9 $ 3,104.6 $ 2,693.4
Fuel | Sales Revenue, Product Line | Product Concentration Risk                          
Concentration Risk [Line Items]                          
Net sales and other revenue                 $ 2,664.0 $ 2,785.4      
Percentage of total net sales and other revenue                 5.70% 6.00% 5.70% 5.20% 4.50%
Other                          
Concentration Risk [Line Items]                          
Net sales and other revenue                     $ 799.3 $ 711.7 $ 767.9
Other | Sales Revenue, Product Line | Product Concentration Risk                          
Concentration Risk [Line Items]                          
Net sales and other revenue                 $ 686.0 $ 600.4      
Percentage of total net sales and other revenue                 1.50% 1.30% 1.30% 1.20% 1.30%